1) D-Galactosamine pentaacetate
D-半乳糖胺五乙酸酯
2) beta-D-Galactose pentaacetate
beta-D-半乳糖五乙酸酯
3) D-Galactosamine hydrochloride
D-盐酸半乳糖胺
4) D-GalN
D-半乳糖胺
1.
Objective To study the effect of Yugan Tablet on acute liver injuries induced by D-galactosamine(D-GalN)in mice.
目的研究愈肝片对D-半乳糖胺(D-GlaN)所致小鼠急性肝损伤的影响。
2.
Methods: Two acute hepatic injury models induced by carbon tetrachloride (CCl4) and D-galactosamine (D-GalN) in mice were used.
方法:CCl_4和D-半乳糖胺小鼠肝脏损伤模型,以测定血清谷丙氨酸转换酶(ALT)、谷草氨基酸转换酶(AST)和肝匀浆丙二醛(MDA)含量为指标观察丹参酮ⅡA对肝脏损伤的保护作用。
5) D-galactosamine
D-半乳糖胺
1.
Pathogenesis of D-galactosamine(D-GalN)-and Lipopolysaccharides(LPS)-induced Fulminant Hepatic Failure
D-半乳糖胺和脂多糖介导大鼠急性肝衰竭的机理研究
2.
MethodsChemical liver injury models were made by D-galactosamine and Carbon tetrachloride and ALT,AST activities and MDA were detemined.
方法分别采用CCl4和D-半乳糖胺作为化学毒物制成急性肝损伤模型,采用赖氏法测定各组动物血清丙氨酸氨基转移酶(ALT)和血清天门冬氨酸氨基转移酶(AST)的活性,并测定肝匀浆MDA含量。
3.
METHODS: Acute hepatic injury was induced by intraperitoneal(ip) injection of carbon tetrachloride and D-galactosamine,respectively.
方法:分别采用四氯化碳(CC l4)和D-半乳糖胺(D-galactosam ine,D-Gal)腹腔注射造成大鼠急性肝损伤,测定血清生化指标,并测体重和肝脏重、脾重和胸腺重,求脏器系数。
6) D-aminogalactose
D半乳糖胺
补充资料：D-半乳糖
分子式：C6H12O6
分子量：暂无
CAS号：59-23-4
性质：暂无
制备方法：暂无
用途：营养药。
分子量：暂无
CAS号：59-23-4
性质：暂无
制备方法：暂无
用途：营养药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条